Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
CLA3884 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15534 | 28857324 | J Gastroenterol Hepatol | Physical activity levels and hepatic steatosis: A longitudinal follow-up study in adults. | 2018 | Details |
| A15547 | 28848738 | Front Cardiovasc Med | Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance. | 2017 | Details |
| A15553 | 28846061 | Metab Syndr Relat Disord | Obstetric Outcomes in Women with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15555 | 28845491 | Med Ultrason | Non-alcoholic fatty liver disease, bulb carotid intima-media thickness and obesity phenotypes: results of a prospective observational study. | 2017 | Details |
| A15561 | 28842937 | J Magn Reson Imaging | Optimization of region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification. | 2017 | Details |
| A15572 | 28839428 | World J Gastroenterol | From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. | 2017 | Details |
| A15594 | 28823616 | Clin Biochem | Serum microRNA profiles in patients with chronic hepatitis B, chronic hepatitis C, primary biliary cirrhosis, autoimmune hepatitis, nonalcoholic steatohepatitis, or drug-induced liver injury. | 2017 | Details |
| A15596 | 28823367 | Hepatobiliary Pancreat Dis Int | Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A15629 | 28802062 | Hepatology | Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. | 2017 | Details |
| A15639 | 28796299 | Eur J Clin Invest | Complement C3 and fatty liver disease in Rheumatoid arthritis patients: a cross-sectional study. | 2017 | Details |
| A15650 | 28787358 | J Clin Gastroenterol | The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients. | 2018 | Details |
| A15686 | 28759939 | Horm Metab Res | Effects of a Low-Calorie, Low-Carbohydrate Soy Containing Diet on Systemic Inflammation Among Patients with Nonalcoholic Fatty Liver Disease: A Parallel Randomized Clinical Trial. | 2017 | Details |
| A15700 | 28752524 | Aliment Pharmacol Ther | Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD. | 2017 | Details |
| A15701 | 28752050 | Mol Metab | Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders. | 2017 | Details |
| A15714 | 28748119 | J Adv Res | Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. | 2016 | Details |
| A15725 | 28741298 | Hepatology | Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A15727 | 28741270 | J Gastroenterol | Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease. | 2017 | Details |
| A15732 | 28739572 | Mol Pharmacol | Altenusin, a Nonsteroidal Microbial Metabolite, Attenuates Nonalcoholic Fatty Liver Disease by Activating the Farnesoid X Receptor. | 2017 | Details |
| A15733 | 28738057 | PLoS One | The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study. | 2017 | Details |
| A15758 | 28724274 | Acta Med Iran | The Correlation Between Liver Fat Content and Ulcerative Colitis Disease Severity. | 2017 | Details |
| A15764 | 28722242 | Diabetes Obes Metab | Therapeutic application of GPR119 ligands in metabolic disorders. | 2017 | Details |
| A15783 | 28711489 | Life Sci | Time-course microarrays reveal early activation of the immune transcriptome in a choline-deficient mouse model of liver injury. | 2017 | Details |
| A15819 | 28694655 | World J Gastroenterol | Antioxidant dietary approach in treatment of fatty liver: New insights and updates. | 2017 | Details |
| A15829 | 28691342 | Mol Nutr Food Res | Dual function of Lactobacillus kefiri DH5 in preventing high-fat-diet-induced obesity: direct reduction of cholesterol and upregulation of PPAR-α in adipose tissue. | 2017 | Details |
| A15830 | 28691103 | J Clin Transl Res | Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. | 2017 | Details |
| A15839 | 28687713 | Clin Sci (Lond) | TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival. | 2017 | Details |
| A15843 | 28686220 | Children (Basel) | The Association between Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk in Children. | 2017 | Details |
| A15846 | 28685131 | Can J Gastroenterol Hepatol | Relationship between Nonalcoholic Fatty Liver Disease and Vitamin D Nutritional Status in Extreme Obesity. | 2017 | Details |
| A15854 | 28680048 | Sci Rep | Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults. | 2017 | Details |
| A15856 | 28679028 | Liver Int | Hepatic iron is the major determinant of serum ferritin in NAFLD patients. | 2017 | Details |
| A15859 | 28678199 | Int J Mol Sci | The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver. | 2017 | Details |
| A15861 | 28677739 | Mol Med Rep | Protein profiling and functional analysis of liver mitochondria from rats with nonalcoholic steatohepatitis. | 2017 | Details |
| A15865 | 28676973 | Eur J Nutr | Chronic consumption of fructose in combination with trans fatty acids but not with saturated fatty acids induces nonalcoholic steatohepatitis with fibrosis in rats. | 2017 | Details |
| A15870 | 28676332 | Respir Physiol Neurobiol | Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity. | 2017 | Details |
| A15871 | 28676027 | Curr Vasc Pharmacol | The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options? | 2018 | Details |
| A15893 | 28667176 | J Mol Endocrinol | miR-212-5p suppresses lipid accumulation by targeting FAS and SCD1. | 2017 | Details |
| A15903 | 28660148 | J Clin Transl Hepatol | Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15906 | 28658094 | Medicine (Baltimore) | Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management. | 2017 | Details |
| A15949 | 28640216 | Nutrients | A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15952 | 28638585 | Middle East J Dig Dis | Clinicopathological Study of Seronegative Celiac Disease in Adults in Pakistan: A Pilot Study. | 2017 | Details |
| A15963 | 28636830 | Appl Physiol Nutr Metab | Attenuation of hepatic steatosis by purple sweet potato colour is associated with blocking Src/ERK/C/EBPβ signalling in high-fat-diet-treated mice. | 2017 | Details |
| A15967 | 28635128 | J Biophotonics | Development of a classification model for non-alcoholic steatohepatitis (NASH) using confocal Raman micro-spectroscopy. | 2017 | Details |
| A15973 | 28632181 | Nutrients | Spirulina Protects against Hepatic Inflammation in Aging: An Effect Related to the Modulation of the Gut Microbiota? | 2017 | Details |
| A15985 | 28626963 | Exp Physiol | Exercise training modulates the hepatic renin-angiotensin system in fructose-fed rats. | 2017 | Details |
| A15989 | 28624576 | Gastroenterology | Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15999 | 28620012 | Clin Sci (Lond) | Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes. | 2017 | Details |
| A16004 | 28616057 | J Res Med Sci | Serum omentin-1, vaspin, and apelin levels and central obesity in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A16012 | 28612285 | J Endocrinol Invest | Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. | 2017 | Details |
| A16024 | 28605159 | Obesity (Silver Spring) | Differential Impact of Weight Loss on Nonalcoholic Fatty Liver Resolution in a North American Cohort with Obesity. | 2017 | Details |
| A16035 | 28598780 | Clin Exp Rheumatol | The liver in familial Mediterranean fever: is it involved? | 2017 | Details |
| A16056 | 28591572 | Cell Rep | Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans. | 2017 | Details |
| A16069 | 28585725 | Aliment Pharmacol Ther | Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population. | 2017 | Details |
| A16092 | 28575232 | J Clin Endocrinol Metab | Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial. | 2017 | Details |
| A16120 | 28554682 | Clin Gastroenterol Hepatol | Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. | 2017 | Details |
| A16134 | 28545368 | Curr Med Chem | Improving Metabolic Control Through Functional Foods. | 2019 | Details |
| A16146 | 28539716 | Pharmacogn Mag | Prevention Mechanism of 2,3,5,4'-Tetrahydroxy-stilbene-2-O-β-D-glucoside on Lipid Accumulation in Steatosis Hepatic L-02 Cell. | 2017 | Details |
| A16156 | 28533742 | Front Mol Neurosci | Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms? | 2017 | Details |
| A16171 | 28525362 | Horm Mol Biol Clin Investig | FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases. | 2017 | Details |
| A16172 | 28524171 | Nat Rev Endocrinol | Endocrine-disrupting chemicals and fatty liver disease. | 2017 | Details |
| A16177 | 28521680 | Curr Med Chem | Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis. | 2019 | Details |
| A16189 | 28511168 | Wiad Lek | [The nonalcoholic steatohepatitis influence on the course and progression of ischemic heart disease]. | 2017 | Details |
| A16226 | 28500084 | J Endocrinol | Bisphenol A promotes hepatic lipid deposition involving Kupffer cells M1 polarization in male mice. | 2017 | Details |
| A16230 | 28497593 | J Gastroenterol Hepatol | Polymorphism of receptor-type tyrosine-protein phosphatase delta gene in the development of non-alcoholic fatty liver disease. | 2018 | Details |
| A16233 | 28494548 | Zhonghua Gan Zang Bing Za Zhi | [The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis]. | 2017 | Details |
| A16236 | 28493388 | Hepatology | Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease. | 2017 | Details |
| A16240 | 28489307 | Liver Int | Non-alcoholic fatty liver and advanced fibrosis in the elderly: Results from a community-based Polish survey. | 2017 | Details |
| A16267 | 28478385 | J Biol Chem | Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism. | 2017 | Details |
| A16273 | 28473066 | J Am Coll Radiol | ACR Appropriateness Criteria® Chronic Liver Disease. | 2017 | Details |
| A16289 | 28470683 | Hepatology | How healthy are the "Healthy volunteers"? Penetrance of NAFLD in the biomedical research volunteer pool. | 2017 | Details |
| A16294 | 28469367 | Ann Gastroenterol | Long-term change in incidence and risk factors of cirrhosis and hepatocellular carcinoma in Crete, Greece: a 25-year study. | 2017 | Details |
| A16300 | 28468951 | Clin Sci (Lond) | Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease. | 2017 | Details |
| A16306 | 28467925 | Cell Metab | Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16336 | 28452101 | Diabetes Obes Metab | Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial. | 2017 | Details |
| A16340 | 28448433 | Int J Environ Res Public Health | Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children. | 2017 | Details |
| A16348 | 28443804 | J Am Coll Nutr | 25(OH)D Levels in Relation to Gender, Overweight, Insulin Resistance, and Inflammation in a Cross-Sectional Cohort of Northern Italian Workers: Evidence in Support of Preventive Health Care Programs. | 2017 | Details |
| A16354 | 28442120 | Gastroenterology | American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. | 2017 | Details |
| A16382 | 28426876 | Carcinogenesis | Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis. | 2017 | Details |
| A16387 | 28425154 | Hepatol Res | Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study. | 2017 | Details |
| A16404 | 28415736 | Oncotarget | The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease. | 2017 | Details |
| A16405 | 28414763 | PLoS One | Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations. | 2017 | Details |
| A16423 | 28402022 | J Cell Biochem | Steroidogenic Acute Regulatory Protein (StAR) Overexpression Reduces Inflammation and Insulin Resistance in Obese Mice. | 2017 | Details |
| A16448 | 28381741 | Intern Med | Non-alcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-aged Japanese Men and Women. | 2017 | Details |
| A16456 | 28376114 | PLoS One | High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal. | 2017 | Details |
| A16484 | 28359548 | Gastroenterol Hepatol | Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population. | 2017 | Details |
| A16489 | 28358620 | Metab Syndr Relat Disord | Daily Coffee Intake Inhibits Pancreatic Beta Cell Damage and Nonalcoholic Steatohepatitis in a Mouse Model of Spontaneous Metabolic Syndrome, Tsumura-Suzuki Obese Diabetic Mice. | 2017 | Details |
| A16497 | 28352941 | Diabetologia | EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral? | 2017 | Details |
| A16501 | 28350839 | PLoS One | Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study. | 2017 | Details |
| A16511 | 28346857 | Metab Syndr Relat Disord | The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome. | 2017 | Details |
| A16515 | 28346237 | Curr Opin Gastroenterol | Current and future pharmacologic treatment of nonalcoholic steatohepatitis. | 2017 | Details |
| A16516 | 28345673 | Sci Rep | Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes. | 2017 | Details |
| A16528 | 28335383 | Int J Mol Sci | A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets. | 2017 | Details |
| A16533 | 28332301 | J Diabetes | Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease. | 2017 | Details |
| A16534 | 28330852 | FASEB J | A controlled-release mitochondrial protonophore reverses hypertriglyceridemia, nonalcoholic steatohepatitis, and diabetes in lipodystrophic mice. | 2017 | Details |
| A16546 | 28323377 | J Magn Reson Imaging | Accuracy of PDFF estimation by magnitude-based and complex-based MRI in children with MR spectroscopy as a reference. | 2017 | Details |
| A16549 | 28322783 | Biochem Biophys Res Commun | Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model. | 2017 | Details |
| A16560 | 28317281 | Mol Nutr Food Res | Comparison of dietary polyphenols for protection against molecular mechanisms underlying nonalcoholic fatty liver disease in a cell model of steatosis. | 2017 | Details |
| A16566 | 28303724 | Drug Metab Rev | Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. | 2017 | Details |
| A16582 | 28297799 | Zhonghua Gan Zang Bing Za Zhi | [A serum lipidomic study of patients with non-alcoholic fatty liver disease]. | 2017 | Details |
| A16593 | 28294174 | Eur J Clin Nutr | Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study. | 2017 | Details |
| A16596 | 28293093 | World J Gastroenterol | Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. | 2017 | Details |